Ribosome biogenesis may augment resistance training-induced myofiber hypertrophy and is required for myotube growth in vitro

Am J Physiol Endocrinol Metab. 2016 Apr 15;310(8):E652-E661. doi: 10.1152/ajpendo.00486.2015. Epub 2016 Feb 9.

Abstract

Resistance exercise training (RT) is the most effective method for increasing skeletal muscle mass in older adults; however, the amount of RT-induced muscle growth is highly variable between individuals. Recent evidence from our laboratory and others suggests ribosome biogenesis may be an important factor regulating RT-induced hypertrophy, and we hypothesized that the extent of hypertrophy is at least partly regulated by the amount of RT-induced ribosome biogenesis. To examine this, 42 older adults underwent 4 wk of RT aimed at inducing hypertrophy of the knee extensors (e.g., 2 sets of squat, leg press, and knee extension, 10-12 repetition maximums, 3 days/wk), and vastus lateralis muscle biopsies were performed pre- and post-RT. Post hoc K-means cluster analysis revealed distinct differences in type II myofiber hypertrophy among subjects. The percent change in type II myofiber size in nonresponders (Non; n = 17) was -7%, moderate responders (Mod; n = 19) +22%, and extreme responders (Xtr; n = 6) +83%. Total muscle RNA increased only in Mod (+9%, P < 0.08) and Xtr (+26%, P < 0.01), and only Xtr increased rRNA content (+40%, P < 0.05) and myonuclei/type II fiber (+32%, P < 0.01). Additionally, Mod and Xtr had a greater increase in c-Myc protein levels compared with Non (e.g., approximately +350 and +250% vs. +50%, respectively, P < 0.05). In vitro studies showed that growth factor-induced human myotube hypertrophy is abolished when rRNA synthesis is knocked down using the Pol I-specific inhibitor CX-5461. Overall, these data implicate ribosome biogenesis as a key process regulating the extent of RT-induced myofiber hypertrophy in older adults.

Keywords: Pol I; c-Myc; rRNA; ribosome; skeletal muscle.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Benzothiazoles / pharmacology
  • Cluster Analysis
  • Female
  • Humans
  • Hypertrophy
  • Immunohistochemistry
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Muscle Fibers, Fast-Twitch / metabolism
  • Muscle Fibers, Skeletal / drug effects
  • Muscle Fibers, Skeletal / metabolism*
  • Muscle, Skeletal / growth & development
  • Muscle, Skeletal / metabolism
  • Naphthyridines / pharmacology
  • Organelle Biogenesis*
  • Proto-Oncogene Proteins c-myc / metabolism
  • Quadriceps Muscle / growth & development*
  • Quadriceps Muscle / metabolism
  • RNA / metabolism
  • RNA Polymerase I / antagonists & inhibitors
  • RNA, Ribosomal / drug effects
  • RNA, Ribosomal / metabolism*
  • Resistance Training*
  • Ribosomes / metabolism*

Substances

  • Benzothiazoles
  • CX 5461
  • MYC protein, human
  • Naphthyridines
  • Proto-Oncogene Proteins c-myc
  • RNA, Ribosomal
  • RNA
  • RNA Polymerase I